Geron Corp. (GERN)
1.225
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 12:01
Geron Free Cash Flow (Quarterly) : -16.05M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.05M |
| March 31, 2026 | -63.16M |
| December 31, 2025 | -22.07M |
| September 30, 2025 | -13.49M |
| June 30, 2025 | -27.42M |
| March 31, 2025 | -47.98M |
| December 31, 2024 | -43.80M |
| September 30, 2024 | -58.94M |
| June 30, 2024 | -53.68M |
| March 31, 2024 | -62.87M |
| December 31, 2023 | -41.00M |
| September 30, 2023 | -51.03M |
| June 30, 2023 | -29.80M |
| March 31, 2023 | -46.74M |
| December 31, 2022 | -35.32M |
| September 30, 2022 | -29.75M |
| June 30, 2022 | -28.71M |
| March 31, 2022 | -34.02M |
| December 31, 2021 | -22.27M |
| September 30, 2021 | -22.93M |
| June 30, 2021 | -17.81M |
| March 31, 2021 | -32.74M |
| December 31, 2020 | -12.62M |
| September 30, 2020 | -15.45M |
| June 30, 2020 | -12.59M |
| Date | Value |
|---|---|
| March 31, 2020 | -26.38M |
| December 31, 2019 | -10.46M |
| September 30, 2019 | -12.24M |
| June 30, 2019 | -8.767M |
| March 31, 2019 | -12.78M |
| December 31, 2018 | -3.017M |
| September 30, 2018 | -6.145M |
| June 30, 2018 | -4.495M |
| March 31, 2018 | -7.368M |
| December 31, 2017 | -4.387M |
| September 30, 2017 | -4.424M |
| June 30, 2017 | -4.438M |
| March 31, 2017 | -7.307M |
| December 31, 2016 | -0.633M |
| September 30, 2016 | -6.553M |
| June 30, 2016 | -5.636M |
| March 31, 2016 | -5.604M |
| December 31, 2015 | -5.292M |
| September 30, 2015 | -4.905M |
| June 30, 2015 | -6.335M |
| March 31, 2015 | -7.712M |
| December 31, 2014 | 28.36M |
| September 30, 2014 | -4.484M |
| June 30, 2014 | -5.15M |
| March 31, 2014 | -9.505M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Precigen, Inc. | -18.20M |
| Editas Medicine, Inc. | -29.67M |
| Agenus, Inc. | -31.20M |
| Amgen, Inc. | 3.489B |
| Anika Therapeutics, Inc. | -2.133M |